Persistent but dysfunctional mucosal SARS-CoV-2-specific IgA and low lung IL-1β associate with COVID-19 fatal outcome: A cross-sectional analysis
María Julia Ruiz(Centre National de la Recherche Scientifique), Morgane Bomsel(Centre National de la Recherche Scientifique), Diego Cantoni(Medway School of Pharmacy), Gabriel Siracusano(Vita-Salute San Raffaele University), Daniela Tudor(Délégation Paris 5), Pierre Moine(Inserm), Mathieu Godement, Guillaume Géri(Hôpital Avicenne), Hanqing Liao(University of Oxford), Djillali Annane(Hôpital Raymond-Poincaré), Jean‐Daniel Chiche(Université Paris Cité), Nigel Temperton(Medway School of Pharmacy), Arielle R. Rosenberg(Institut de Virologie), Claudia Pastori(Vita-Salute San Raffaele University), Fernando Real(Universidade Federal de São Paulo), Nicola Ternette(University of Dundee), Elisabeth Cramer Bordé(Université de Versailles Saint-Quentin-en-Yvelines), Aiwei Zhu(Capital Medical University), Andréa Cottignies-Calamarte(Centre National de la Recherche Scientifique), Claude Capron(Hôpital Ambroise-Paré), Lucia Lopalco(Vita-Salute San Raffaele University)
Cited by 17
Related Papers
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
|JAMA|2016|28.1k
Surviving Sepsis Campaign
|Critical Care Medicine|2013|9.7k
Surviving Sepsis Campaign: International Guidelines for Management of Severe Sepsis and Septic Shock, 2012
|Intensive Care Medicine|2013|7.3k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Intensive Care Medicine|2017|6.8k
Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016
|Critical Care Medicine|2017|3.8k